IAG Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213K | Buy |
1,149
+4
| +0.3% | +$742 | 0.03% | 111 |
|
|
2025
Q1 | $240K | Sell |
1,145
-20
| -2% | -$4.19K | 0.04% | 99 |
|
|
2024
Q4 | $207K | Sell |
1,165
-104
| -8% | -$18.5K | 0.04% | 98 |
|
|
2024
Q3 | $251K | Buy |
1,269
+173
| +16% | +$34.2K | 0.05% | 90 |
|
|
2024
Q2 | $188K | Sell |
1,096
-67
| -6% | -$11.5K | 0.04% | 95 |
|
|
2024
Q1 | $212K | Buy |
1,163
+425
| +58% | +$77.4K | 0.05% | 90 |
|
|
2023
Q4 | $114K | Sell |
738
-73
| -9% | -$11.3K | 0.03% | 106 |
|
|
2023
Q3 | $121K | Buy |
811
+42
| +5% | +$6.26K | 0.03% | 98 |
|
|
2023
Q2 | $104K | Buy |
769
+3
| +0.4% | +$404 | 0.03% | 113 |
|
|
2023
Q1 | $122K | Sell |
766
-33
| -4% | -$5.26K | 0.03% | 94 |
|
|
2022
Q4 | $129K | Sell |
799
-42
| -5% | -$6.78K | 0.04% | 87 |
|
|
2022
Q3 | $113K | Buy |
841
+85
| +11% | +$11.4K | 0.04% | 85 |
|
|
2022
Q2 | $116K | Buy |
756
+25
| +3% | +$3.84K | 0.04% | 83 |
|
|
2022
Q1 | $118K | Buy |
731
+41
| +6% | +$6.62K | 0.04% | 85 |
|
|
2021
Q4 | $93K | Buy |
690
+3
| +0.4% | +$404 | 0.03% | 89 |
|
|
2021
Q3 | $75K | Buy |
687
+102
| +17% | +$11.1K | 0.03% | 95 |
|
|
2021
Q2 | $66K | Buy |
585
+103
| +21% | +$11.6K | 0.02% | 102 |
|
|
2021
Q1 | $53K | Buy |
482
+2
| +0.4% | +$220 | 0.02% | 107 |
|
|
2020
Q4 | $52K | Buy |
480
+2
| +0.4% | +$217 | 0.02% | 107 |
|
|
2020
Q3 | $42K | Buy |
478
+186
| +64% | +$16.3K | 0.02% | 110 |
|
|
2020
Q2 | $29K | Sell |
292
-9
| -3% | -$894 | 0.01% | 131 |
|
|
2020
Q1 | $23K | Buy |
301
+2
| +0.7% | +$153 | 0.02% | 134 |
|
|
2019
Q4 | $27K | Buy |
+299
| New | +$27K | 0.02% | 153 |
|